Cargando…
S131: A RANDOMISED ASSESSMENT OF THE SEQUENTIAL ADDITION OF THE KINASE INHIBITOR QUIZARTINIB TO INTENSIVE CHEMOTHERAPY IN OLDER ACUTE MYELOID LEUKAEMIA (AML) PATIENTS: RESULTS FROM THE NCRI AML18 TRIAL
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428467/ http://dx.doi.org/10.1097/01.HS9.0000967436.08196.70 |
| _version_ | 1785090476638994432 |
|---|---|
| author | Knapper, Steven Thomas, Abin King, Sophie Thomas, Ian Gilkes, Amanda Irwin, Sarah Sellar, Robert Green, Simone Overgaard, Ulrik Malthe Mehta, Priyanka Dennis, Mike Freeman, Sylvie Russell, Nigel |
| author_facet | Knapper, Steven Thomas, Abin King, Sophie Thomas, Ian Gilkes, Amanda Irwin, Sarah Sellar, Robert Green, Simone Overgaard, Ulrik Malthe Mehta, Priyanka Dennis, Mike Freeman, Sylvie Russell, Nigel |
| author_sort | Knapper, Steven |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428467 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104284672023-08-17 S131: A RANDOMISED ASSESSMENT OF THE SEQUENTIAL ADDITION OF THE KINASE INHIBITOR QUIZARTINIB TO INTENSIVE CHEMOTHERAPY IN OLDER ACUTE MYELOID LEUKAEMIA (AML) PATIENTS: RESULTS FROM THE NCRI AML18 TRIAL Knapper, Steven Thomas, Abin King, Sophie Thomas, Ian Gilkes, Amanda Irwin, Sarah Sellar, Robert Green, Simone Overgaard, Ulrik Malthe Mehta, Priyanka Dennis, Mike Freeman, Sylvie Russell, Nigel Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428467/ http://dx.doi.org/10.1097/01.HS9.0000967436.08196.70 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Knapper, Steven Thomas, Abin King, Sophie Thomas, Ian Gilkes, Amanda Irwin, Sarah Sellar, Robert Green, Simone Overgaard, Ulrik Malthe Mehta, Priyanka Dennis, Mike Freeman, Sylvie Russell, Nigel S131: A RANDOMISED ASSESSMENT OF THE SEQUENTIAL ADDITION OF THE KINASE INHIBITOR QUIZARTINIB TO INTENSIVE CHEMOTHERAPY IN OLDER ACUTE MYELOID LEUKAEMIA (AML) PATIENTS: RESULTS FROM THE NCRI AML18 TRIAL |
| title | S131: A RANDOMISED ASSESSMENT OF THE SEQUENTIAL ADDITION OF THE KINASE INHIBITOR QUIZARTINIB TO INTENSIVE CHEMOTHERAPY IN OLDER ACUTE MYELOID LEUKAEMIA (AML) PATIENTS: RESULTS FROM THE NCRI AML18 TRIAL |
| title_full | S131: A RANDOMISED ASSESSMENT OF THE SEQUENTIAL ADDITION OF THE KINASE INHIBITOR QUIZARTINIB TO INTENSIVE CHEMOTHERAPY IN OLDER ACUTE MYELOID LEUKAEMIA (AML) PATIENTS: RESULTS FROM THE NCRI AML18 TRIAL |
| title_fullStr | S131: A RANDOMISED ASSESSMENT OF THE SEQUENTIAL ADDITION OF THE KINASE INHIBITOR QUIZARTINIB TO INTENSIVE CHEMOTHERAPY IN OLDER ACUTE MYELOID LEUKAEMIA (AML) PATIENTS: RESULTS FROM THE NCRI AML18 TRIAL |
| title_full_unstemmed | S131: A RANDOMISED ASSESSMENT OF THE SEQUENTIAL ADDITION OF THE KINASE INHIBITOR QUIZARTINIB TO INTENSIVE CHEMOTHERAPY IN OLDER ACUTE MYELOID LEUKAEMIA (AML) PATIENTS: RESULTS FROM THE NCRI AML18 TRIAL |
| title_short | S131: A RANDOMISED ASSESSMENT OF THE SEQUENTIAL ADDITION OF THE KINASE INHIBITOR QUIZARTINIB TO INTENSIVE CHEMOTHERAPY IN OLDER ACUTE MYELOID LEUKAEMIA (AML) PATIENTS: RESULTS FROM THE NCRI AML18 TRIAL |
| title_sort | s131: a randomised assessment of the sequential addition of the kinase inhibitor quizartinib to intensive chemotherapy in older acute myeloid leukaemia (aml) patients: results from the ncri aml18 trial |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428467/ http://dx.doi.org/10.1097/01.HS9.0000967436.08196.70 |
| work_keys_str_mv | AT knappersteven s131arandomisedassessmentofthesequentialadditionofthekinaseinhibitorquizartinibtointensivechemotherapyinolderacutemyeloidleukaemiaamlpatientsresultsfromthencriaml18trial AT thomasabin s131arandomisedassessmentofthesequentialadditionofthekinaseinhibitorquizartinibtointensivechemotherapyinolderacutemyeloidleukaemiaamlpatientsresultsfromthencriaml18trial AT kingsophie s131arandomisedassessmentofthesequentialadditionofthekinaseinhibitorquizartinibtointensivechemotherapyinolderacutemyeloidleukaemiaamlpatientsresultsfromthencriaml18trial AT thomasian s131arandomisedassessmentofthesequentialadditionofthekinaseinhibitorquizartinibtointensivechemotherapyinolderacutemyeloidleukaemiaamlpatientsresultsfromthencriaml18trial AT gilkesamanda s131arandomisedassessmentofthesequentialadditionofthekinaseinhibitorquizartinibtointensivechemotherapyinolderacutemyeloidleukaemiaamlpatientsresultsfromthencriaml18trial AT irwinsarah s131arandomisedassessmentofthesequentialadditionofthekinaseinhibitorquizartinibtointensivechemotherapyinolderacutemyeloidleukaemiaamlpatientsresultsfromthencriaml18trial AT sellarrobert s131arandomisedassessmentofthesequentialadditionofthekinaseinhibitorquizartinibtointensivechemotherapyinolderacutemyeloidleukaemiaamlpatientsresultsfromthencriaml18trial AT greensimone s131arandomisedassessmentofthesequentialadditionofthekinaseinhibitorquizartinibtointensivechemotherapyinolderacutemyeloidleukaemiaamlpatientsresultsfromthencriaml18trial AT overgaardulrikmalthe s131arandomisedassessmentofthesequentialadditionofthekinaseinhibitorquizartinibtointensivechemotherapyinolderacutemyeloidleukaemiaamlpatientsresultsfromthencriaml18trial AT mehtapriyanka s131arandomisedassessmentofthesequentialadditionofthekinaseinhibitorquizartinibtointensivechemotherapyinolderacutemyeloidleukaemiaamlpatientsresultsfromthencriaml18trial AT dennismike s131arandomisedassessmentofthesequentialadditionofthekinaseinhibitorquizartinibtointensivechemotherapyinolderacutemyeloidleukaemiaamlpatientsresultsfromthencriaml18trial AT freemansylvie s131arandomisedassessmentofthesequentialadditionofthekinaseinhibitorquizartinibtointensivechemotherapyinolderacutemyeloidleukaemiaamlpatientsresultsfromthencriaml18trial AT russellnigel s131arandomisedassessmentofthesequentialadditionofthekinaseinhibitorquizartinibtointensivechemotherapyinolderacutemyeloidleukaemiaamlpatientsresultsfromthencriaml18trial |